90 related articles for article (PubMed ID: 19012935)
1. Annexin A3 in urine: a highly specific noninvasive marker for prostate cancer early detection.
Schostak M; Schwall GP; Poznanović S; Groebe K; Müller M; Messinger D; Miller K; Krause H; Pelzer A; Horninger W; Klocker H; Hennenlotter J; Feyerabend S; Stenzl A; Schrattenholz A
J Urol; 2009 Jan; 181(1):343-53. PubMed ID: 19012935
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer biomarker annexin A3 detected in urines obtained following digital rectal examination presents antigenic variability.
Hamelin-Peyron C; Vlaeminck-Guillem V; Haïdous H; Schwall GP; Poznanović S; Gorius-Gallet E; Michel S; Larue A; Guillotte M; Ruffion A; Choquet-Kastylevsky G; Ataman-Önal Y
Clin Biochem; 2014 Jul; 47(10-11):901-8. PubMed ID: 24954692
[TBL] [Abstract][Full Text] [Related]
3. Pathobiological functions and clinical implications of annexin dysregulation in human cancers.
Prieto-Fernández L; Menéndez ST; Otero-Rosales M; Montoro-Jiménez I; Hermida-Prado F; García-Pedrero JM; Álvarez-Teijeiro S
Front Cell Dev Biol; 2022; 10():1009908. PubMed ID: 36247003
[TBL] [Abstract][Full Text] [Related]
4. Role of annexin A3 in breast cancer (Review).
Ozturk A
Mol Clin Oncol; 2022 Jun; 16(6):111. PubMed ID: 35620213
[TBL] [Abstract][Full Text] [Related]
5. Annexin A3 and cancer.
Liu C; Li N; Liu G; Feng X
Oncol Lett; 2021 Dec; 22(6):834. PubMed ID: 34712358
[TBL] [Abstract][Full Text] [Related]
6. 33-kDa ANXA3 isoform contributes to hepatocarcinogenesis
Guo C; Li N; Dong C; Wang L; Li Z; Liu Q; Ma Q; Greenaway FT; Tian Y; Hao L; Liu S; Sun MZ
J Adv Res; 2021 May; 30():85-102. PubMed ID: 34026289
[TBL] [Abstract][Full Text] [Related]
7. A Comprehensive Urine Proteome Database Generated From Patients With Various Renal Conditions and Prostate Cancer.
Swensen AC; He J; Fang AC; Ye Y; Nicora CD; Shi T; Liu AY; Sigdel TK; Sarwal MM; Qian WJ
Front Med (Lausanne); 2021; 8():548212. PubMed ID: 33928097
[TBL] [Abstract][Full Text] [Related]
8. Integrin Alpha V in Urine: A Novel Noninvasive Marker for Prostate Cancer Detection.
Zemskova MY; Marinets MV; Sivkov AV; Pavlova JV; Shibaev AN; Sorokin KS
Front Oncol; 2020; 10():610647. PubMed ID: 33791193
[TBL] [Abstract][Full Text] [Related]
9. Fluorescent Lipo-Beads for the Sensitive Detection of Phospholipase A
Hossain S; Pai KR; Piyasena ME
ACS Biomater Sci Eng; 2020 Apr; 6(4):1989-1997. PubMed ID: 33455318
[TBL] [Abstract][Full Text] [Related]
10. Affinity Captured Urinary Extracellular Vesicles Provide mRNA and miRNA Biomarkers for Improved Accuracy of Prostate Cancer Detection: A Pilot Study.
Davey M; Benzina S; Savoie M; Breault G; Ghosh A; Ouellette RJ
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172003
[TBL] [Abstract][Full Text] [Related]
11. Annexin A3 in sepsis: novel perspectives from an exploration of public transcriptome data.
Toufiq M; Roelands J; Alfaki M; Syed Ahamed Kabeer B; Saadaoui M; Lakshmanan AP; Bangarusamy DK; Murugesan S; Bedognetti D; Hendrickx W; Al Khodor S; Terranegra A; Rinchai D; Chaussabel D; Garand M
Immunology; 2020 Dec; 161(4):291-302. PubMed ID: 32682335
[TBL] [Abstract][Full Text] [Related]
12. Approaches to urinary detection of prostate cancer.
Eskra JN; Rabizadeh D; Pavlovich CP; Catalona WJ; Luo J
Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):362-381. PubMed ID: 30655600
[TBL] [Abstract][Full Text] [Related]
13. Approaches to the discovery of non-invasive urinary biomarkers of prostate cancer.
Jedinak A; Loughlin KR; Moses MA
Oncotarget; 2018 Aug; 9(65):32534-32550. PubMed ID: 30197761
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid and hyaluronidase as possible novel urine biomarkers for the diagnosis of prostate cancer.
Skarmoutsos I; Skarmoutsos A; Katafigiotis I; Tataki E; Giagini A; Adamakis I; Alamanis C; Duvdevani M; Sitaras N; Constantinides C
Med Oncol; 2018 May; 35(7):97. PubMed ID: 29802604
[TBL] [Abstract][Full Text] [Related]
15. Novel biomarkers for the detection of prostate cancer.
Jakobsen NA; Hamdy FC; Bryant RJ
J Clin Urol; 2016 Dec; 9(2 Suppl):3-10. PubMed ID: 28344810
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics analysis of differentially expressed proteins in prostate cancer based on proteomics data.
Chen C; Zhang LG; Liu J; Han H; Chen N; Yao AL; Kang SS; Gao WX; Shen H; Zhang LJ; Li YP; Cao FH; Li ZG
Onco Targets Ther; 2016; 9():1545-57. PubMed ID: 27051295
[TBL] [Abstract][Full Text] [Related]
17. Urinary proteomics and metabolomics studies to monitor bladder health and urological diseases.
Chen Z; Kim J
BMC Urol; 2016 Mar; 16():11. PubMed ID: 27000794
[TBL] [Abstract][Full Text] [Related]
18. HOX transcription factors are potential targets and markers in malignant mesothelioma.
Morgan R; Simpson G; Gray S; Gillett C; Tabi Z; Spicer J; Harrington KJ; Pandha HS
BMC Cancer; 2016 Feb; 16():85. PubMed ID: 26867567
[TBL] [Abstract][Full Text] [Related]
19. The use of a gas chromatography-sensor system combined with advanced statistical methods, towards the diagnosis of urological malignancies.
Aggio RB; de Lacy Costello B; White P; Khalid T; Ratcliffe NM; Persad R; Probert CS
J Breath Res; 2016 Feb; 10(1):017106. PubMed ID: 26865331
[TBL] [Abstract][Full Text] [Related]
20. Urinary Volatile Organic Compounds for the Detection of Prostate Cancer.
Khalid T; Aggio R; White P; De Lacy Costello B; Persad R; Al-Kateb H; Jones P; Probert CS; Ratcliffe N
PLoS One; 2015; 10(11):e0143283. PubMed ID: 26599280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
